Furthermore, SLC30A9 knockdown led to a remarkable decrease in the growth of cervical cancer xenografts, further emphasizing its potential as a valuable target for therapeutic strategies in the treatment of cervical cancer. This evidence concerns the gene SLC30A9 and cervical carcinoma.